We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its lead drug candidate comprises CUE-101, a variant ... Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its lead drug candidate comprises CUE-101, a variant form of the cytokine Interleukin-2 and a T cell antigen to target and activate T cells specific to HPV-related cancers. The other products under pipeline are CUE-102, CUE-103, CUE-400, and CUE-401. Show more
BOSTON, April 08, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively modulate...
BOSTON, April 02, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively modulate...
BOSTON, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively modulate...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.05 | -3.22580645161 | 1.55 | 1.67 | 1.47 | 216001 | 1.57057352 | CS |
| 4 | -0.4 | -21.0526315789 | 1.9 | 2.08 | 1.47 | 260836 | 1.77505502 | CS |
| 12 | -1.3 | -46.4285714286 | 2.8 | 2.8 | 1.47 | 261951 | 2.04349372 | CS |
| 26 | -0.26 | -14.7727272727 | 1.76 | 3.2491 | 1.47 | 309301 | 2.39331056 | CS |
| 52 | -2.15 | -58.904109589 | 3.65 | 5.12 | 1.47 | 344368 | 3.04852578 | CS |
| 156 | -11.04 | -88.038277512 | 12.54 | 18.42 | 1.47 | 317929 | 6.18422577 | CS |
| 260 | -6.7 | -81.7073170732 | 8.2 | 35.5 | 1.47 | 282944 | 9.50959087 | CS |
Hawkeye_tt
12 months ago
conix
2 years ago
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
